The multiyear study will start later in 2021 and enroll participants across age ranges with varying cognitive performance levels to develop biomarkers that can identify early signs of mild cognitive impairment, Biogen said.
“The successful development of digital biomarkers in brain health would help address the significant need to accelerate patient diagnoses and empower physicians and individuals to take timely action,” Michel Vounatsos, Biogen CEO, said in a press release.
More articles on digital transformation:
Telemedicine tops digital health funding in 2020 at $3.2B: 4 things to know
Duke medical school appoints chief science and digital officer
5 Mass General Brigham innovation projects awarded funding
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
